Alva Review-Courier -

'Blood money'? Purdue settlement would rely on opioid sales

 

September 18, 2019



The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin.

That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal.

"The settlement agreement basically requires the settlement payments to be made based on the future sales and profits of opioids. That doesn't really feel to me like the right way to do this," Massachusetts Gov. Charlie Baker said this week.

Massachusetts is among several states that have pledged to continu...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2019